Jaguar Health (JAGX) Short-term Investments (2025 - 2026)
Jaguar Health (JAGX) reported Short-term Investments of $2.8 million for Q1 2026, up 765.22% quarter-over-quarter from $322000.0 in Q4 2025.
Jaguar Health (JAGX) Short-term Investments (2025 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 2 years of Short-term Investments data on file, last reported at $2.8 million in Q1 2026.
- Short-term Investments for Q1 2026 came in at $2.8 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (changed N/A YoY), and the FY2025 annual result was $322000.0, changed N/A from the prior year.
- Short-term Investments rose to $2.8 million in Q1 2026 per JAGX's latest filing, from $322000.0 in the prior quarter.
- Over five years, Short-term Investments peaked at $2.8 million in Q1 2026 and troughed at $322000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.79 Mn |
| Dec 31, 2025 | 322,000.00 |